Cargando…
In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis
Schistosomiasis has been a fatal obstinate disease that threatens global human health, resulting in the granulomatous inflammation and liver fibrosis. Objective:The aim of this study was to evaluate the therapeutic effects and mechanisms of hydroxyasiaticoside combined with praziquantel in the treat...
Autores principales: | Fang, Huilong, Yu, Ling, You, Da, Peng, Nan, Guo, Wanbei, Wang, Junjie, Zhang, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862569/ https://www.ncbi.nlm.nih.gov/pubmed/33553120 http://dx.doi.org/10.3389/fbioe.2020.613784 |
Ejemplares similares
-
Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo
por: Peng, Wei, et al.
Publicado: (2022) -
Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis
por: Qadeer, Abdul, et al.
Publicado: (2022) -
The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review
por: Niu, Xuehua, et al.
Publicado: (2022) -
Editorial: Delivery systems in biologics-based therapeutics
por: Dirisala, Anjaneyulu, et al.
Publicado: (2023) -
Investigation of the Antibacterial Activity and in vivo Cytotoxicity of Biogenic Silver Nanoparticles as Potent Therapeutics
por: Hossain, Md. Monir, et al.
Publicado: (2019)